Clinical Trial Update: ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating docetaxel as adjuvant therapy for elderly breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED